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Objectives: The incretin hormone glucagon-like peptide-1 (GLP-1) is secreted from intestinal L-cells upon nutrient intake. While recent evidence
has shown that GLP-1 is released in a circadian manner in rats, whether this occurs in mice and if this pattern is regulated by the circadian clock
remain to be elucidated. Furthermore, although circadian GLP-1 secretion parallels expression of the core clock gene Bmal1, the link between the
two remains largely unknown. Secretagogin (Scgn) is an exocytotic SNARE regulatory protein that demonstrates circadian expression and is
essential for insulin secretion from b-cells. The objective of the current study was to establish the necessity of the core clock gene Bmal1 and the
SNARE protein SCGN as essential regulators of circadian GLP-1 secretion.
Methods: Oral glucose tolerance tests were conducted at different times of the day on 4-hour fasted C57BL/6J, Bmal1 wild-type, and Bmal1
knockout mice. Mass spectrometry, RNA-seq, qRT-PCR and/or microarray analyses, and immunostaining were conducted on murine (m) and
human (h) primary L-cells and mGLUTag and hNCI-H716 L-cell lines. At peak and trough GLP-1 secretory time points, the mGLUTag cells were
co-stained for SCGN and a membrane-marker, ChIP was used to analyze BMAL1 binding sites in the Scgn promoter, protein interaction with
SCGN was tested by co-immunoprecipitation, and siRNA was used to knockdown Scgn for GLP-1 secretion assay.
Results: C57BL/6J mice displayed a circadian rhythm in GLP-1 secretion that peaked at the onset of their feeding period. Rhythmic GLP-1
release was impaired in Bmal1 knockout (KO) mice as compared to wild-type controls at the peak (p < 0.05) but not at the trough secretory
time point. Microarray identiﬁed SNARE and transport vesicle pathways as highly upregulated in mGLUTag L-cells at the peak time point of GLP-1
secretion (p < 0.001). Mass spectrometry revealed that SCGN was also increased at this time (p < 0.001), while RNA-seq, qRT-PCR, and
immunostaining demonstrated Scgn expression in all human and murine primary L-cells and cell lines. The mGLUTag and hNCI-H716 L-cells
exhibited circadian rhythms in Scgn expression (p < 0.001). The ChIP analysis demonstrated increased binding of BMAL1 only at the peak of
Scgn expression (p < 0.01). Immunocytochemistry showed the translocation of SCGN to the cell membrane after stimulation at the peak time
point only (p < 0.05), while CoIP showed that SCGN was pulled down with SNAP25 and b-actin, but only the latter interaction was time-
dependent (p < 0.05). Finally, Scgn siRNA-treated cells demonstrated signiﬁcantly blunted GLP-1 secretion (p < 0.01) in response to stimu-
lation at the peak time point only.
Conclusions: These data demonstrate, for the ﬁrst time, that mice display a circadian pattern in GLP-1 secretion, which is impaired in Bmal1
knockout mice, and that Bmal1 regulation of Scgn expression plays an essential role in the circadian release of the incretin hormone GLP-1.
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1. INTRODUCTION
Circadian rhythms act as an anticipatory mechanism preparing or-
ganisms for the constant 24-hour lightedark cycle [1,2]. The main
zeitgeber (ZT), light, entrains a network of clock genes in the supra-
chiasmatic nuclei of the hypothalamus, where these rhythms are
orchestrated [1,3]. At the molecular level, these rhythms are generated
by heterodimerization of the core clock protein BMAL1 with CLOCK and
subsequent binding to E-box promoter elements to stimulate the
transcription of Period (Per) 1e3 and Cryptochrome (Cry) 1e2. The
expression of Per and Cry, in turn, represses Bmal1 and Clock,
completing the transcriptional feedback loop. The clock genes are
known to be expressed in all nucleated mammalian cells, both cen-
trally and in peripheral tissues, and are estimated to drive the rhythmic
expression of approximately 43% of all protein-encoding genes [1,4].
Although light is the strongest ZT, nutrient intake can also synchronize
peripheral metabolic tissues. The gastrointestinal tract, b-cell, liver,
skeletal muscle, and adipose tissue [5e14] have been shown to
exhibit endogenous circadian rhythmicity, ultimately coordinating
metabolic homeostasis with the 24-hour feedingefasting cycle. In the
well-characterized b-cell, insulin exhibits a diurnal rhythm in secretion
and this pattern in insulin release is more pronounced when nutrients
are delivered orally rather than intravenously [15]. This implicates
temporal incretin secretion as an essential link between nutrient
ingestion and deposition through the upregulation of glucose-
stimulated insulin secretion.
It was previously reported that the enteroendocrine incretin hormone
glucagon-like peptide-1 (GLP-1) is secreted in a circadian manner
from enteroendocrine L-cells in rats and humans [16e20]. Although
circadian GLP-1 secretion has been extensively tested in rat models
using physiological disruptors such as constant light and obesogenic
feeding [16,18], the lack of appropriate genetically modiﬁed animals
has precluded determination of the role of the molecular clock in
diurnal GLP-1 secretion. Circadian activity has also been shown in the
murine (m) GLUTag and human (h) NCI-H716 L-cell lines, which exhibit
cell-autonomous rhythmic patterns in Bmal1, with GLP-1 secretion
paralleling Bmal1 expression [16,17,21]. Furthermore, suppression of
Bmal1 with palmitate in mGLUTag L-cells is associated with dampened
GLP-1 release, while primary intestinal cultures generated from Bmal1
KO mice also demonstrate decreased GLP-1 secretion [18,21].
Nonetheless, the molecular mechanism linking Bmal1 expression to
circadian GLP-1 secretion remains largely unknown.
Interestingly, impaired GLP-1 secretion has been observed in both cell
and animal models of SNARE deﬁciency. The SNARE proteins mediate
fusion of the secretory granule to the cell membrane, enabling
exocytosis of the granule contents [22,23] and, indeed, the SNARE
proteins, VAMP2, SYNTAXIN1A, and SYNAPTOTAGMIN-7, have been
demonstrated to play essential roles in GLP-1 secretion [24e26];
however, it is uncertain if these proteins regulate secretion in a tem-
poral manner. Evidence from a- and b-cells suggests that SNAREs and
their accessory regulators exhibit rhythmic expression [27,28]. Sec-
retagogin (SCGN), a SNARE-regulatory protein [29e31], has been
identiﬁed as rhythmic in these cell types and has been shown to be
essential for insulin secretion from b-cells [27,28,30,32,33]. SCGN is a
calcium-binding protein that interacts with the core SNARE protein
SNAP25 and b-actin in b-cells, both of which are also known to be
involved in GLP-1 secretion by L-cells [24,30,32,34]. Given these
similarities between b-cells and L-cells, SCGN was identiﬁed as a
potential target linking circadian Bmal1 expression to GLP-1 secretion.
Herein, for the ﬁrst time, we deﬁne a circadian rhythm in GLP-1
secretion in mice, which is dependent on the core clock geneMOLECULAR METABOLISM 31 (2020) 124e137  2019 The Author(s). Published by Elsevier GmbH. This
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where it exhibits circadian expression under the transcriptional regu-
lation of BMAL1. This drives a subsequent time-dependent recruitment
of SCGN toward the L-cell membrane that in turn facilitates circadian
secretion of GLP-1. When taken together, we identiﬁed a novel
regulator of circadian GLP-1 secretion, which could have implications
for time-sensitive treatments as well as the potential for SNAREs as
targets for type 2 diabetes therapies.
2. METHODS
2.1. Animals
Male and female C57Bl/6J mice and Bmal1þ/ mice were purchased
from Jackson Laboratories (Bar Harbor, ME, USA). The Bmal1þ/ mice
were bred and genotyped according to the recommended protocol to
generate sex-, age-, and littermate-matched wild-type (WT) and KO
animals. The mice had free access to water and a regular chow diet
(Teklad) for the duration of the study and were allowed to acclimate for
one week to the 12-hour light, 12-hour dark (lights on at 06:00 or
Zeitgeber Time (ZT) 0) and constant room temperature conditions at
the animal facility before use. All experimental procedures were
approved by the Animal Care Committee of the University of Toronto.
2.2. Oral glucose tolerance tests
Oral glucose tolerance tests (OGTTs) were conducted on 4-hour fasted
mice with their basal blood glucose obtained prior to the administration
of an oral gavage of glucose at a concentration of 5 g/kg of body weight
[25]. OGTTs were conducted on the C57Bl/6J mice at ZT2, 6, 10, 14,
18, and 22. The nighttime studies were carried out under a red light;
two tests were conducted on most animals with a one-week recovery
interval. Bmal1 WT and KO mice were tested at the trough (ZT2) and
peak (ZT14) time points of GLP-1 secretion established in the C57Bl/6J
mice. Blood was collected from the tail vein at 0 min and then 10 and
60 min after the oral gavage to measure the glucose using a OneTouch
meter (LifeScan, Burnaby, BC, Canada) and the plasma GLP-1 and
insulin levels using a MesoScale Discovery (MSD) assay for the total
GLP-1.
2.3. Cell culture
Male mGLUTag cells were used as a model of intestinal L-cells due to
their close representation of in vivo GLP-1 secretion [16,21]. The cells
were grown in DMEM with 25 mmol/L glucose and 10% FBS [16,21].
Male hNCI-H716 cells were used as a human L-cell model because
they respond to known GLP-1 secretagogues [17,35]. They were
grown in suspension in cell culture ﬂasks with RPMI 1640 medium
containing 10% FBS and 100 U/ml penicillin/streptomycin. For the
experiments, hNCI-H716 cells were plated onto cell culture plates
coated with 0.5 g/ml Corning Matrigel (Thermo Fisher Scientiﬁc,
Waltham, MA, USA).
2.4. In vitro synchronization
For all of the circadian experiments, the cells were synchronized using
a previously established protocol [16e18,21]. In brief, the cells were
grown for two days from the last split and starved in an appropriate
media containing 0.5% FBS for 12 h to induce quiescence. The cells
were then synchronized with 20 mM forskolin (SigmaeAldrich, Oak-
ville, ON, Canada) for 1 h, after which the media was changed to
growing media for up to 48 h. While previous reports suggest that
certain synchronizing agents generate more robust rhythms than
others [36], forskolin was used as a synchronizer because it has been
previously shown to elicit a strong circadian response in immortalizedis an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 125
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also tested with the mGLUTag L-cells, but resulted in signiﬁcant cell
death after 24 h (unpublished data).
2.5. Human and murine primary cell RNA sequencing
Fluorescent-assisted cell sorting (FACS) of L-cells, either via the
expression of the ﬂuorescent reporter Venus in transgenic mice or
staining with ﬂuorescent antibodies in human tissue isolates, was
described previously [37]. RNA isolation and sequencing is described
in [37,38] and the data were deposited in the NCBI GEO repository
(human, GSE114853; mouse, GSE114913). The studies were con-
ducted in accordance with the principles of the Declaration of Helsinki
and good clinical practice. Human ethical approval was provided by
Cambridge Central and South Research ethics committees (Ref: 09/
H0308/24, 16/EE/0338, and 15/EE/0152), the Inserm ethics com-
mittee, and Agence de la Biomédecine (Ref: PFS16-004). The animal
research was regulated under the Animals (Scientiﬁc Procedures) Act
1986 Amendment Regulations 2012 and conducted following an
ethical review by the University of Cambridge Animal Welfare and
Ethical Review Body.
2.6. hNCI-H716 cell RNA sequencing
Total RNA was extracted using an RNeasy Plus Mini Kit (Qiagen) ac-
cording to the manufacturer’s instructions and the samples were
tested using an Agilent BioAnalyzer to assess their integrity (visual
electropherogram inspection and RIN score). Sequencing libraries
were prepared using an Illumina TruSeq RNA Library Prep Kit v2 with
polyA selection and run on an Illumina HiSeq 2500 using Rapid Flow
Cell v2 at the Harvard University’s Bauer Sequencing Core, with 76
cycle paired end reads as part of a larger multiplex group of barcoded
RNA sample libraries. FASTQC v0.11.8 detected no unexpected con-
ditions in the resulting reads. The reads (minus the last base) were
aligned to human genome assembly 38 and gene models from GEN-
CODE v28 primary assembly using STAR 2.6.0 [39]. Gene read
quantiﬁcation was performed using RSEM v1.3.1 [40]. Genes with very
low total expression (total expected counts< 1, lowþ high conditions)
were removed and the remainder normalized using the trimmed mean
of M-values method [41] as implemented in the edgeR R package. The
log2 counts per million (CPM) were estimated with a prior default of
0.25 CPM per gene. The data were deposited in the NCBI GEO re-
pository (human, GSE136369).
2.7. Microarray analysis
The RNA was extracted, reverse-transcribed, and subjected to
microarray analysis at the Ontario Cancer Institute Genomics Centre
(Toronto, ON, Canada) using a mouse WG-6 V2 Illumina BeadChip as
previously reported [16]. Gene ontology enrichment data were obtained
from the Walter and Eliza Hall Institute of Medical Research bioinfor-
matics resource on August 20, 2019 (http://bioinf.wehi.edu.au/
software/MSigDB/mouse_c5_v5p2.rdata). The data were deposited
in the NCBI GEO repository (human, GSE136573).
2.8. Gene expression analyses
Total RNA from FACS-sorted cells [37] was isolated using a Microscale
RNA Isolation Kit (Ambion) and reverse transcribed according to
standard protocols. Quantitative RT-PCR was performed with a 7900
HT Fast Real-Time PCR system (Applied Biosystems). The PCR reaction
mix consisted of ﬁrst-strand cDNA template, appropriate TaqMan
probe/primer mix, and PCR Master Mix (Thermo Fisher Scientiﬁc). The
expression of Scgn was compared with that of Actb measured on the
same sample in parallel on the same plate, demonstrating a CT126
 2019 The Author(s). Published by Elsevier Gdifference (DCT). The mean, standard error, and statistical analyses
were performed on the DCT data and only converted to relative
expression levels (2^DCT) for presentation in the ﬁgures.
The total RNA collected from cell lines using a Paris Kit (Thermo Fisher)
was reverse-transcribed using 5X All-In-One Reverse Transcriptase
MasterMix (Applied Biological Materials, Richmond, BC, Canada), and
quantitative RT-PCR was conducted using a TaqMan Fast Mix Gene
Expression Assay with primers (Thermo Fisher Scientiﬁc) as listed in
Table S1. Gene expression was calculated using the DDCt method
[42]. H3f3a (mGLUTag) and Hist1h3a (hNCI-H716) were used as
control genes as they have been previously established to lack
circadian rhythms [16,17,21].
2.9. Mass spectrometry
The mGLUTag cells were grown and synchronized as previously
described, and the total protein was extracted at 8 and 20 h after cell
synchronization using TRIzol reagent. The protein extract was analyzed
via mass spectrometry at the SPARC BioCentre, Hospital for Sick
Children (Toronto, ON, Canada). The data were analyzed using Scaffold
proteome software and the DAVID functional annotation bioinformatics
tool.
2.10. Immunoblotting analyses
Protein was collected using a Paris Kit, quantiﬁed by a Bradford assay,
run on 10% polyacrylamide gel, and transferred onto polyvinylidene
diﬂuoride membranes. The membranes were blocked for 1 h in 5%
skim milk in Tris-buffered saline with 0.1% Tween (TBS-T, Sigmae
Aldrich). The blots were incubated overnight in skim milk TBS-T with
antibodies as listed in Table S2 and washed in TBS-T. Following in-
cubation with anti-rabbit IgG secondary antibodies (Cell Signaling,
Danvers, MA, USA; Table S2) in skim milk TBS-T, the membranes were
imaged with SignalFire Elite Enhanced chemiluminescent reagent (Cell
Signaling) and visualized on a Kodak imaging system (Eastman Kodak
Company, Rochester, NY, USA). When the membranes were re-probed,
the blots were ﬁrst stripped using Restore PLUS Western blotting
stripping buffer (Thermo Fisher Scientiﬁc) and washed in TBS-T.
2.11. Immunoﬂuorescence
Formalin-ﬁxed, parafﬁn-embedded murine (UHN Pathology Services,
Toronto, ON, Canada) and human (OriGene) ileal sections were dew-
axed, rehydrated, and blocked in 10% normal goat serum (NGS)/PBS
for 1 h and then incubated in 10% NGS/PBS with rabbit anti-Scgn (Cell
Signaling) and mouse anti-GLP-1 (Abcam, Inc., Toronto, ON, Canada)
antibodies for 1 h (Table S2), followed by incubation with Alexa Fluor
488- and 555-labeled secondary antibodies (Table S2) for 1 h. The
immunostained cells were counted and compared based on the
presence and/or absence of GLP-1 and SCGN co-staining, with the
average percent distribution determined as the number of cells in each
category divided by the total number of cells observed.
Cells for immunocytochemistry were grown on Falcon multi-chamber
microscope slides. For translocation experiments, the cells were
synchronized as previously described and then treated with 107 M
glucose-dependent insulinotropic polypeptide (GIP, an established
rodent L-cell secretagogue [16e18,21]). Live cells were then incu-
bated in 2.5 mg/ml of wheat germ agglutinin-Alexa Fluor 488 Conjugate
(Thermo Fisher) in HBSS at 37 C for 10 min. All of the cells were then
ﬁxed in 4% paraformaldehyde for 30 min at 37 C, permeabilized with
0.1% Triton X-100 (SigmaeAldrich) in PBS for 20 min, and incubated
in 1% BSA for 30 min at 37 C, followed by incubation with rabbit anti-
Scgn antibody (Table S2). All of the cells were then incubated with
Alexa Fluor 488-labeled secondary antibody for 1 h (Table S2).MOLECULAR METABOLISM 31 (2020) 124e137
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Pearson’s correlation coefﬁcient (PCC) was used to measure the
colocalization of wheat germ agglutinin membrane staining and SCGN
using the mean intensities of the green and red channels, respectively
[43]; a value of zero represents probes that were not correlated with
one another. Regions of interest were generated in an unbiased
manner by outlining the cell membrane. PCC was calculated using NIS-
Elements imaging software (Nikon Corporation).
The stained sections and cells were mounted in Vectashield mounting
medium containing DAPI (Vector Laboratories, Burlington, ON, Can-
ada). Imaging was conducted using a Nikon Swept Field confocal
microscope and immunoﬂuorescence analysis was performed with
NIS-Elements Imaging.
2.12. Chromatin immunoprecipitation assay
Non-canonical E-boxes for BMAL1 [44] (CATG(T/C)G) were identiﬁed in
the 50 Scgn promoter at 672 bp (CATGCG), 1176 bp (CACGCG), and
1252 bp (CATGTG) upstream of the transcription start site. ChIP was
conducted using a SimpleChIP Enzymatic Chromatin IP Kit with
Magnetic Beads #9003 (Cell Signaling) per the manufacturer’s in-
structions. In brief, cell protein was cross-linked to DNA with 37%
formaldehyde for 10 min at room temperature, digested with micro-
coccal nuclease for 20 min at 37 C, and incubated with BMAL1
antibody at 4 C overnight (Table S2). The protein was precipitated
using Protein G magnetic beads and the DNA was eluted from the
beads using a Magnetic Separation Rack (Cell Signaling). The DNA was
ampliﬁed by PCR using SYBR Green [45] with the listed primers
(Table S3).
2.13. Co-immunoprecipitation
Cells were washed with HBSS and lysed with Cell Lysis Buffer (Cell
Signaling). The protein (200 mg in 200 ml of lysis buffer) was incubated
with 4 ml of anti-SNAP25 or anti-Scgn antibody (Table S2) overnight
with rotation, incubated with Protein A Magnetic Beads (New England
Biosystems) for 2 h with rotation, and washed with lysis buffer. The
beads were then placed in 20 ml of 3X Reducing SDS Loading Buffer
(Cell Signaling) and heated at 95 C for 5 min. The protein efﬂuent was
collected using a Magnetic Separation Rack (Cell Signaling) and loaded
directly onto a 10% polyacrylamide gel as previously described for
immunoblotting of SCGN or b-actin, respectively (Table S3).
2.14. siRNA-mediated knockdown
In vitro knockdown studies utilized ON-TARGETplus siRNA for Scgn and
ON-TARGETplus Non-targeting Pool scRNA as a control (Dharmacon
Inc., Lafayette, CO, USA). The RNA constructs were used in combi-
nation with Dharmafect3 using a reverse-transfection protocol as
recommended by the manufacturer (Dharmacon Inc.). To maintain
knockdown in the synchronization experiments, the media for both
starvation (0.5% FBS) and serum shock (10% FBS with forskolin) steps
and all subsequent incubations included siRNA or scRNA in combi-
nation with Dharmafect3 as appropriate. Cells were then extracted for
qRT-PCR or analyzed for GLP-1 secretion.
2.15. GLP-1 secretion assay
Cells were incubated for 2 h in DMEM with 0.5% FBS containing
107 M GIP or vehicle alone (control). As previously noted, GIP was
used as a secretagogue due to its ability to reliably stimulate temporal
GLP-1 release by rodent L-cells [16e18,21]. Peptides in the media
and cells were collected by reversed-phase adsorption using Sep-Pak
cartridges (Waters Associates, Milford, MA, USA), and the GLP-1 levels
were measured using a Total GLP-1 Radioimmunoassay Kit (Millipore,
Etobicoke, ON, Canada). All of the data are expressed as percentMOLECULAR METABOLISM 31 (2020) 124e137  2019 The Author(s). Published by Elsevier GmbH. This
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divided by the total (media þ cells) GLP-1 content.
2.16. Statistical analyses
All data are expressed as mean SEM. The delta area under the curve
(DAUC) was calculated using the trapezoidal rule for the changes in
hormonal and glycemic responses from fasting over the entire 60-min
study. In vivo circadian data were tested for signiﬁcant 24-hour
rhythms using CircWave software (www.hutlab.nl). In vitro rhythmic
analyses enabling the identiﬁcation of the signiﬁcant period was
calculated using MetaCycle [46,47] and curves were plotted using a
damped sine feature with GraphPad Prism. All other ﬁgures were
analyzed for signiﬁcance via ANOVA (1-, 2-, or 3-way) followed by
Tukey’s test as appropriate. Differential expression analysis of the
microarray and protein expression was performed using linear models
through the R package limma.
3. RESULTS
3.1. Circadian GLP-1 secretion is dependent on the core clock
gene Bmal1
To establish whether GLP-1 secretion follows a circadian rhythm in
mice, 4-hour fasted C57Bl6/J mice were administered an identical oral
glucose load at six time points throughout a 24-hour day. Fasting levels
of GLP-1, insulin, and blood glucose varied slightly by time of day
(Figures 1A and S1A). Therefore, to directly compare the L-cell
secretory response to the same OGTT over the course of the day, the
data were examined as the change from the basal levels. As expected,
plasma GLP-1 increased at 10 min post oral gavage at all times of the
day; however, the peak response was observed at ZT14, which aligns
with the onset of the dark, the feeding period in mice (Figure 1A).
Representation of the data as the DAUC generated a curve that
signiﬁcantly (p < 0.05) ﬁt to a 24-hour rhythm, with a peak at ZT14
and a corresponding trough at ZT2 (Figure 1B). The plasma insulin and
blood glucose concentrations also increased at all time points after the
oral glucose load (Figure S1A).
Although we previously established that ex vivo adult mouse ileal crypt
cultures generated from Bmal1 KO mice have impaired GLP-1
secretory capacity [21], time-dependent GLP-1 secretion had not yet
been determined in vivo in these animals. We therefore conducted
OGTTs at the established trough (ZT2) and peak (ZT14) of the GLP-1
secretion in 4 h-fasted Bmal1 KO compared to WT (control) mice.
Consistent with their known impairment in pancreatic b-cell function
[9], the KO mice demonstrated impaired insulin release at both time
points (Figure S1B), with corresponding hyperglycemia (Figure S1C).
The WT mice displayed greater GLP-1 secretion at ZT14 than ZT2,
conﬁrming the pattern observed in the C57Bl6/J mice. In contrast, the
KO mice demonstrated a loss of the normal peak and trough rhythm,
with markedly impaired GLP-1 release at the peak (ZT14) time point of
secretion only (p < 0.05; Figure 1CeD). Taken together, these data
establish a circadian pattern in GLP-1 secretion in the mouse that
depends on the expression of the core clock gene Bmal1.
3.2. Identiﬁcation of secretagogin as a potential regulator of
circadian GLP-1 secretion
To identify targets linking the rhythmic expression of Bmal1 to the
circadian secretion of GLP-1, a microarray analysis was conducted on
the synchronized mGLUTag cells at the previously reported peak (4 h)
and trough (16 h) of Arntl (Bmal1) mRNA expression [16,17] (see also
Figure 4A,F). Although no genes were signiﬁcantly downregulated, 13
genes were identiﬁed that were signiﬁcantly upregulated (p < 0.05;is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 127
Figure 1: Circadian GLP-1 secretion is dependent on the core clock gene Bmal1. (A-B) OGTTs were conducted on 4-hour fasted C57Bl/6J mice at six time points throughout
a 24-hour light (open bars)-dark (closed bars) cycle (ZT0 ¼ 06:00), with individual plots for each time point represented in (A) and the 24-hour DAUC proﬁle represented in (B). (C-
D) OGTTs were performed on 4-hour fasted Bmal1 WT and KO mice at ZT2 and ZT14 with individual plots for each time point shown in (C) and the DAUC of each timepoint
represented in (D). (A and C) t0 indicates the absolute fasting values for GLP-1 in pg/ml. n ¼ 4e8 mice for all time points in all of the experiments. *p < 0.05.
Original ArticleTable S4), including the positive control Arntl (log2 fold-
change ¼ 1.103288, p < 0.05). Furthermore, 34 pathways relating to
vesicle transport were signiﬁcantly different between the two time
points (p < 0.05; Table S5), including the GO transport vesicle
(Figure 2A) and GO SNARE complex (Figure S2), which were both
signiﬁcantly upregulated at the 4-hour time point. The GO transport
vesicle includes proteins that move cargo between the ER and Golgi or
to the membranes for secretion, including the SNARE proteins iden-
tiﬁed in the GO SNARE complex. This group also includes transcripts
for accessory proteins that facilitate vesicle/granule transport, such as
Scgn and Stxbp1. A number of genes in this pathway that are essential
for secretion from the L-cells were increased with Bmal1 at the 4-hour
time point (Figure 2B) as well as the transcript for Scgn. In addition,
given the importance of the actin cytoskeleton in GLP-1 secretion [34]
and a recently reported interaction between SCGN and b-actin [32],
GO-actin cytoskeleton (Figure S3) was identiﬁed as a signiﬁcantly
upregulated pathway at the 4-hour time point (p < 0.05), which in-
cludes Actb, Stx1b, Vamp2, and Snap25. Collectively, these ﬁndings
suggest possible roles for vesicle transport and/or SNARE proteins in
the regulation of circadian GLP-1 secretion.
To further screen for targets mediating the temporal secretion of GLP-
1, the proteome of the synchronized mGLUTag cells was studied at the
peak (8 h) and trough (20 h) time points of GLP-1 secretion [16] (see
also Figure 8E). Mass spectrometry analysis identiﬁed 2,050 proteins
with a <5% false-positive detection rate, including 1,749 known
proteins, with 333 proteins upregulated at the 8-hour time point and
414 proteins upregulated at the 20-hour time point. SCGN was128
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peak of GLP-1 secretion (8 h). Gene set enrichment analysis
(Figure 2D) of the mass spectrometry data identiﬁed several pathways
matching the microarray ﬁndings, including the upregulation of pro-
teins related to secretory granules (including SGCN), protein transport,
and the actin cytoskeleton (both including b-actin) at the 8-hour time
point.
RNA-seq analysis conducted on intestinal cells collected from murine
Gcg-Venus mice revealed that Scgn was expressed at higher levels in
L-cells in the ileum and colon than other intestinal epithelial cells
(p < 0.001 and p < 0.01, respectively; Figure 3A). Scgn expression
was also analyzed by RT-qPCR and compared between colonic Lþ/L-
cells and mGLUTag cells, conﬁrming that colonic L-cells express more
secretagogin than non-L-cells (p < 0.05, Figure 3B). In addition, hu-
man jejunal L-cells were compared with enteroendocrine cells (EECs)
and other intestinal epithelial cells for SCGN expression, with both L-
cells and EECs expressing more secretagogin than the negative con-
trols (p < 0.01e0.001, Figure 3C).
Murine (Figure 3D) and human (Figure 3E) ileal sections were also
immunostained to assess the co-expression of secretagogin with GLP-
1. Analysis of the percent distribution of SCGNþ and GLP-1þ cells
(Figure 3FeG) revealed that SCGN was expressed in all of the GLP-1þ
cells. SCGN was also identiﬁed in a signiﬁcant number of GLP-1- cells.
However, the murine ileal samples had a higher percentage of
SCGNþ:GLP-1þ cells than SCGNþ GLP-1- cells in the crypts
(p < 0.001), whereas this distribution was reversed in human ileal
tissue (p < 0.001).MOLECULAR METABOLISM 31 (2020) 124e137
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Figure 2: Identiﬁcation of potential targets regulating circadian GLP-1 secretion. (A) Heat maps of GO transport vesicle and (B) selected L-cell secretory genes identiﬁed by
microarray in synchronized the mGLUTag L-cells showing log2 fold-change between the two time points, 4 and 16 h (n ¼ 3 for each time point). (C) Volcano plot of the mass
spectrometry results of the synchronized mGLUTag L-cells at peak (8 h) and trough (20 h) of GLP-1 secretion (n ¼ 3 for each time point). SCGN is indicated by the open circle. (D)
Pathway enrichment analysis of protein clusters that were up regulated at each time point, with SCGN identiﬁed under the secretory granules cluster.To determine the expression of several genes of interest in our cell
models, microarray and RNA-seq analyses were conducted on the
mGLUTag (Figure 3H) and hNCI-H716 (Figure 3I) cells, respectively.
Transcripts for Scgn/SCGN were expressed in both cell lines and in
those for proglucagon (Gcg; the prohormone for GLP-1) and a variety
of different known clock (Arntl, Per2, Nr1d1, and Rora) and SNARE
(Stx1a, Vamp2, Snap25, Scgn, and Stxbp1) proteins. Immunostaining
further demonstrated that SCGN was localized to both the nucleus
and cytoplasm of the mGLUTag (Figure 3J) and hNCI-H716
(Figure 3K) cells. Collectively, these ﬁndings demonstrate the
expression of secretagogin in the murine and human L-cell both
in vivo and in vitro.
3.3. Scgn is expressed in a circadian manner in murine and human
L-cells
To further investigate the rhythmic expression of secretagogin, mRNA
was extracted from synchronized mGLUTag cells every 4 h for 48 h. The
circadian expression of Arntl (p < 0.001; Figure 4A) and anti-phasicMOLECULAR METABOLISM 31 (2020) 124e137  2019 The Author(s). Published by Elsevier GmbH. This
www.molecularmetabolism.comexpression of Per2 (p ¼ 0.06; Figure 4B) was used as a positive con-
trol for the synchronization as previously reported [16,21]. Scgn mRNA
expression peaked at 0 h, with a period of 24 h (p< 0.001; Figure 4C),
consistent with a circadian rhythm. To further analyze the rhythmic
properties of secretagogin, protein was also collected and analyzed for
the circadian expression of BMAL1 (Figure 4D) and SCGN (Figure 4E).
Although the pattern in BMAL1 did not reach signiﬁcance, SCGN
demonstrated a signiﬁcant circadian rhythm (p< 0.001), peaking at 4 h
with a period of 28 h. Similar analyses of BMAL1 (Figure 4F) and PER2
(Figure 4G) transcripts over 36 h in the hNCI-H716 cells revealed pre-
viously reported patterns of expression, similarly validating the syn-
chronization of the cells in this model [17]. SCGN also demonstrated
strong circadian expression in these cells, peaking at 22 h with a period
of 24 h (p < 0.001, Figure 4H).
3.4. Temporal interactions of BMAL1 with the Scgn promoter
To test whether Scgn expression may be driven by BMAL1 binding to
the Scgn promoter, ChIP analysis was conducted on synchronizedis an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 129
Figure 3: Scgn is expressed in primary and immortalized murine and human L-cells. (A) RNA-seq analysis of Scgn in murine Gcg-Venus L-cells and Venus-negative cells
from duodenal, ileal, and colonic sections (n ¼ 2e3 for each cell population). (B) RT-qPCR for Scgn in murine colonic Gcg-Venus L-cells, Venus-negative cells, and mGLUTag L-
cells (n ¼ 3 for each cell population). (C) RNA-seq analysis for SCGN in human jejunal L-cells, enteroendocrine cells, and non-endocrine intestinal epithelial cells (n ¼ 11 for each
cell population). (D-G) Immunostaining of murine (D) and human (E) ileal sections for SCGN and GLP-1 (representative images of SCGNþ:GLP-1þ (top) and SCGNþ:GLP-1- (bottom)
cells are shown). Cell count histogram for murine (F) and human (G) ileal SCGN and/or GLP-1 stained cells (n ¼ 5 sections for each species; a total ofw100 cells were counted per
section). (H-I) Microarray analysis of mGLUTag cells (n ¼ 6) (H) and RNA-seq analysis of hNCI-H716 cells (n ¼ 2) (I) for proglucagon, clock, and SNARE protein transcripts. (J-K)
Immunostaining of mGLUTag (J) and hNCI-H716 (K) L-cells for SCGN; DAPI shows the nuclear stain (representative images of n ¼ 4 are shown). *p < 0.05, **p < 0.01,
***p < 0.001.
Original ArticlemGLUTag cells at time points both before and during the peak and
trough of BMAL1 expression and GLP-1 secretion (at 4 and 8 h vs 16
and 20 h). Noncanonical E-boxes were identiﬁed in the Scgn pro-
moter at 672, 1176, and 1252 bp upstream of the transcription start
site (Figure 5A). ChIP analysis (Figure 5B) revealed increased binding
at two sites (672 and 1252 bp) during the peak (4e8 h)
compared to the trough (16e20 h) time points (p < 0.05), consistent
with a role for BMAL1 in the circadian pattern of Scgn expression.130
 2019 The Author(s). Published by Elsevier G3.5. Secretagogin is recruited to the plasma membrane and binds
b-actin but not SNAP25 in a temporal manner
To determine whether secretagogin is recruited to the membrane
following the stimulation of GLP-1 secretion, the synchronized
mGLUTag cells were analyzed by immunocytochemistry to examine
the SGCN localization. At the 8-hour time point, increased localization
of SCGN at the plasma membrane was observed 60 min after
stimulation with the known GLP-1 secretagogue, GIP [16,17]MOLECULAR METABOLISM 31 (2020) 124e137
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 4: Scgn expression is circadian in mGLUTag and hNCI-H716 L-cells. (A-C) mRNA and (D-E) protein expression over 48 h in synchronized mGLUTag L-cells for Bmal1
(A), Per2 (B), Scgn (C), BMAL1 (D), and SCGN (E; n ¼ 8, conducted as 4 replicates from each of 2 independent splits; representative blots are shown in (D-E)). (F-G) mRNA
expression over 36 h in synchronized hNCI-H716 cells for BMAL1 (F), PER2 (G), and SCGN (H; n ¼ 8, conducted as 4 replicates from each of 2 independent splits).
Figure 5: Time-dependent binding of BMAL1 to the Scgn promoter in mGLUTag
L-cells. (A) Three noncanonical BMAL1 E-boxes were identiﬁed at 1252, 1176, and
672 base pairs upstream of the transcription start site. (B) ChIP analysis for the BMAL1
binding sites in the Scgn promoter at 4, 8, 16, and 20 h in synchronized mGLUTag L-
cells (n ¼ 6, conducted as 3 replicates from each of 2 independent splits). *p < 0.05;
###p < 0.001 vs negative control (-IgG).
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recruitment was observed 60 min after stimulation (Figure 6CeD).
To establish whether SCGN interacts with the SNARE machinery and/or
b-actin in L-cells as previously reported in b-cells [30,32,48], the
synchronized mGLUTag cells were treated for 2 h with GIP at both the
8- and 20-hour time points. SNAP25 was then immunoprecipitated (IP)
and the blots were probed for co-IP of SCGN (Figure 7A); alternatively,
SCGN was pulled-down and the blots were probed for b-actin
(Figure 7B). Although SCGN was found to co-IP with SNAP25, no dif-
ferences in interaction were demonstrated based on the clock time or
with GIP stimulation. However, not only was SCGN found to also
interact with b-actin, but the amount of b-actin bound to SCGN
increased with stimulation at the 8-hour time point only (p < 0.05).
Together, these ﬁndings are consistent with b-actin’s role in SCGN
translocation to the plasma membrane during GLP-1 secretion.
3.6. Scgn is essential for peak GLP-1 secretion
To investigate the functional importance of secretagogin in GLP-1
secretion, a GLP-1 secretion experiment was conducted in the syn-
chronized mGLUTag cells following knockdown of Scgn. Sc- and siRNA
treatments had no effect on synchronization, as shown by the expected
anti-phasic expression of Bmal1 and Per2 at the peak and trough time
points (Figure 8AeB). However, secretagogin knockdown was signiﬁcantis an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 131
Figure 6: Time-dependent recruitment of SCGN to the cell membrane in mGLUTag L-cells. (A-B) 8 h and (C-D) 20 h after synchronization, mGLUTag L-cells were treated
with 107 M GIP or vehicle for 0, 10, and 60 min, followed by staining for SCGN and a membrane marker (with wheat germ agglutinin). Co-localization of SCGN with the cell
membrane was determined by Pearson’s correlation coefﬁcient. (n ¼ 4, conducted as 2 replicates from each of 2 independent splits; representative images are shown). *p < 0.05.
Original Articleat both the mRNA and protein levels at 8 and 20 h (p< 0.05, Figure 8Ce
D), while the expression of transcripts for other key SNARE proteins was
unaffected (Figure S4). A GLP-1 secretion assay was then conducted at
the peak (8 h) and trough (20 h) time points under vehicle and GIP-
stimulated conditions. Synchronization of the cells was further
conﬁrmed by the demonstration of higher GLP-1 secretion in response to
GIP at the 8-hour time point compared to the 20-hour time point as
previously reported [16,21] in the scRNA-treated cells (p < 0.05,
Figure 8E). Scgn knockdown had no effect on the basal GLP-1 secretion
at either time point. However, Scgn knockdown decreased GLP-1Figure 7: Time-dependent interactions of SCGN with b-actin but not SNAP25 in mGL
107 M GIP or vehicle for 2 h. (A) Immunoprecipitation of SNAP25 and immunoblotting
conducted as 2 replicates from each of 2 independent splits; representative blots are sho
132
 2019 The Author(s). Published by Elsevier Gsecretion in response to GIP at the 8-hour time point (p < 0.01) but
had no effect at 20 h, demonstrating secretagogin’s role in the circadian
secretion of GLP-1. This loss of response to GIP was observed although
Gipr mRNA expression was actually elevated at 20 h compared to 8 h
after cell synchronization (Figure S5).
4. DISCUSSION
While circadian rhythms are primarily caused by light, peripheral
metabolic tissues can be entrained by food intake. As shift workersUTag L-cells. mGLUTag L-cells were synchronized and then 8 or 20 h later treated with
for SCGN. (B) Immunoprecipitation of SCGN and immunoblotting for b-actin. (n ¼ 4,
wn). *p < 0.05.
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Figure 8: Scgn is essential for peak GLP-1 secretion in mGLUTag L -cells. mGLUTag L-cells were treated with scRNA or Scgn siRNA, synchronized and then 8 or 20 h later
treated with 107 M GIP or vehicle for 2 h. The cells were then analyzed for Bmal1 (A), Per2 (B), Scgn (C), SCGN (a representative blot is shown) (D), and GLP-1 secretion (E)
(n ¼ 8, conducted as 4 replicates from each of 2 independent splits). *p < 0.05, **p < 0.01, ***p < 0.001.have a higher incidence of obesity and type 2 diabetes [49e51], these
epidemiological data implicate diurnal insulin patterns in disease. The
incretin hormones account for approximately 50% of insulin secretion
after a meal [52,53], and secretion by the b-cells is coordinated, at
least in part, by circadian rhythms in GLP-1 release [16]. However,
although GLP-1 secretion by mGLUTag L-cells has been shown to
parallel Bmal1 expression [16], and primary intestinal cultures from
Bmal1 KO mice show decreased GLP-1 secretion ex vivo [21], the
effect of Bmal1 KO on diurnal GLP-1 secretion in vivo remained un-
known. Furthermore, the exact mechanism by which Bmal1 regulates
circadian GLP-1 release is also unclear, although our previous
research demonstrated roles of thyrotrophic embryonic factor and
protein tyrosine phosphatase 4a1 in regulating the peak of GLP-1
release [16]. We have also shown the importance of the Bmal1-
nicotinamide phosphoribosyltransferase (NAMPT) pathway, identi-
fying mitochondrial activity and ATP-dependent cellular metabolism as
essential for peak GLP-1 secretion [21]. The results of the present
study demonstrate that the accessory SNARE protein, secretagogin, is
not only a target of Bmal1, but also plays an essential role in regulating
the peak, but not the trough, of circadian GLP-1 secretion.MOLECULAR METABOLISM 31 (2020) 124e137  2019 The Author(s). Published by Elsevier GmbH. This
www.molecularmetabolism.comPrevious studies of rats identiﬁed a circadian rhythm in the GLP-1
secretory response to an oral glucose load that peaked at ZT10,
just prior to the onset of their dark or active/feeding period [16]. The
mouse model also exhibited circadian GLP-1 secretion in response
to the same stimulus; however, the peak of secretion was slightly
shifted, occurring at ZT14 as the mice entered their feeding period.
These ﬁndings in rodents are consistent in that peak GLP-1 secre-
tion in both species occurs as an anticipatory response to increased
food intake occurring throughout the dark period. Interestingly,
although obesogenic feeding in rats disrupts the rhythm in GLP-1
release such that the normal trough of secretion at the onset of
the light period is lost [18], KO of Bmal1 in mice not only disrupted
rhythmic GLP-1 release, but also impaired GLP-1 secretion at the
peak time point only. Whether these speciﬁc differences in timing
are consequent to the nature of the circadian disruptors utilized and/
or represent species-dependent differences remain unknown.
However, similar differences have been noted in humans, wherein a
phase delay of 3  27 h has been reported to impair GLP-1 release,
whereas a 9-hour phase advance has been reported to have no
effect [54,55].is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 133
Original ArticlePrevious studies demonstrated key roles for several SNARE proteins in
GLP-1 secretion (VAMP2, STX1A, and SYT7) [24e26]. Given the
demonstrated rhythmic expression of SNARE proteins in other endocrine
cell types, such as islet a- and b-cells [28], they are ideally situated to
provide a mechanistic link between circadian Bmal1 expression and
GLP-1 secretion. Furthermore, isolated L-cells from mouse models of
elevated GLP-1 secretion demonstrate changes in vesicle organization
and vesicle localization [56]. Consistent with this evidence, our tran-
scriptomic and proteomic ﬁndings show that the pathways related to
both vesicle transport and the SNARE proteins are upregulated at the
peak GLP-1 secretion time point. SCGN was also found to co-IP with b-
actin as well as with the SNARE protein SNAP25, consistent with ﬁnd-
ings in other cell types, including b-cells [30,48,57].
Actin cytoskeletal pathways were found to be upregulated in the
mGLUTag L-cells at the peak secretory time point by both microarray
and mass spectrometry analysis. This is consistent with studies showing
that the actin cytoskeleton plays an essential role in hormone secretion
by the L-cells and b-cells, wherein actin remodeling upon stimulation is
necessary to permit the stimulation of granule exocytosis [34,58e61]. It
is therefore possible that secretagogin plays a role in this remodeling to
regulate GLP-1 secretion in a temporal manner. In line with this evi-
dence, SCGN has been shown to be important in the organization of the
actin cytoskeleton, interacting with trafﬁcking proteins and regulating
focal adhesion [32,62]. In the b-cells, this interaction of SCGN with actin
has been shown to increase with stimulation [62], a ﬁnding that was
reproduced in our studies in the L-cells, with stimulation causing
increased secretagogin binding to b-actin at the 8-hour time point but
not at 20 h. Further investigation is required to determine if the temporal
b-actin-secretagogin interaction directly affects GLP-1 secretion. How-
ever, interestingly, as the interaction with b-actin was found to be time-
dependent, whereas that with SNAP25 was not, these ﬁndings suggest
an active role for SGCN in the translocation of GLP-1-ﬁlled secretory
granules to the cell membrane and a more permissive role in SNARE-
mediated exocytosis. Further evidence for this is provided by the
demonstration that only peak GLP-1 secretion by the mGLUTag L-cells
was associated with increased translocation of SGCN to the cell
membrane. This is also in agreement with the decreased recruitment of
Scgn to the cell membrane observed at the 20-hour time point, which
potentially explains the trough GLP-1 secretory response observed in this
study and in other publications [16e18,21].
Expressed in a rhythmic manner in both the mGLUTag and hNCI-H716
cells, Scgn transcript levels paralleled those of SCGN with a 4-hour
translational delay. The Scgn expression patterns were also more
consistent with those of Bmal1 in both the murine and human cells,
rather than with that of Per2, which was anti-phasic to Bmal1 and Scgn
in the mGLUTag L-cells, but arrhythmic in the hNCI-H716 L-cells (pre-
sent study and [16,17]). These ﬁndings further conﬁrmed Bmal1 as a
prime target regulating circadian GLP-1 secretion, as was also
demonstrated by ChIP analysis, demonstrating that the Scgn promoter is
a direct target of BMAL1, with greater binding of BMAL1 to 2 E-boxes in
Scgn at the peak compared to the trough time point of GLP-1 secretion.
Interestingly, in vivo loss of Bmal1 and in vitro knockdown of Scgn
resulted in a similar phenotype of loss in GLP-1 secretory rhythm and
impaired secretion only at the peak time point, further suggesting a tight
interplay between Bmal1 and Scgn. Furthermore, consistent with an
essential role of SGCN in circadian GLP-1 secretion, only peak GLP-1
release was reduced by Scgn knockdown. Interestingly, this effect
was observed only with respect to the stimulated GLP-1 release at this
time point, with no observed change in the basal secretion. These
ﬁndings are consistent with studies showing that disruption of the actin
cytoskeleton and syntaxin-1A knockout cause impairments solely in134
 2019 The Author(s). Published by Elsevier Gstimulated compared to basal GLP-1 secretion [25,34]. Similar studies of
NIT-1 b-cells also showed that only second-phase insulin secretion was
altered following Scgn silencing [32]. Indeed, cell stimulation is known to
be essential for SGCN’s role as a calcium sensor, inducing conforma-
tional changes that are required for the facilitation of secretion [29e
31,48,62,63]. In the b-cells, this appears to be due, at least in part,
to inhibition by tomosyn, which dissociates from SCGN when exposed to
calcium, liberating SCGN to interact with its secretory partners, including
actin and SNAP25 [30]. Consistent with this, the secretagogue used in
the present study, GIP, increases the cAMP levels in the L-cells, which is
known to enhance intracellular Ca2þ concentrations and lead to
increased GLP-1 secretion [64]. Finally, other SNARE regulators that
have been suggested to be rhythmic [28] and are known to be essential
for insulin secretion [65,66] were also identiﬁed in the mGLUTag L-cell
proteome as being upregulated at the peak secretion time point,
including the SNARE-accessory protein STXBP-1 (Munc-18). Further
investigation into the role of other potential mediators of circadian GLP-1
secretion is thus warranted.
Importantly, SCGN was identiﬁed in all primary murine and human L-
cells. Given recent evidence demonstrating a diversity of L-cells along
the crypt villus axis [67], L-cell SCGN expression appears to be
ubiquitous, suggesting that it plays an essential role in L-cell function.
Secretagogin may also inﬂuence the development of L-cells, as evi-
dence shows that it plays an essential role in b-cell development and
causes a-cell hyperplasia when knocked out [33]. Recent reports also
implicate reduced secretagogin expression in type 2 diabetes [68e
70], consistent with a report that whole body SCGN KO mice are
glucose intolerant [69]. Given the importance of GLP-1 and, subse-
quently, insulin secretion for the maintenance of glucose homeostasis,
it is possible that some of the effects of altered secretagogin
expression may be L-cell mediated.
It is acknowledged that the Scgn knockdown studies presented herein
were only conducted in vitro. Although the cellular models utilized are
known to be representative of primary L-cells in terms of their GLP-1
secretion and response to secretagogues [16,21,35,71], one draw-
back to in vitro circadian experiments is that in vivo rhythms are
orchestrated by a range of cues, with L-cells synchronized by nutrient
intake and a variety of hormones, neural inputs, cytokines, and the
microbiome. Thus, in vitro experiments are subject to a slow loss of
synchronicity given the absence of such cues, limiting experiments to
48-hour time intervals. Nonetheless, while our cells may lack these
cues, synchronization protocols have been established to mimic these
environments, driving these rhythms as seen in other tissues and cell
types [16e18,21,27,28,72,73]. Additionally, our studies used only
single synchronization protocol (i.e., with forskolin), although studies of
b-cells have shown that multiple different synchronizing agents that
also act through the cAMP-PKA pathway generate similar effects on the
circadian expression of a Per2-luciferase construct [36]. Finally, GIPwas
used as the sole secretagogue in the present study, suggesting that the
results may apply solely to GIP-stimulated GLP-1 secretion; however,
previous studies directly compared the temporal responses to GIP with
those of several other L-cell secretagogues (insulin and bethanechol) in
the mGLUTag L-cells, ﬁnding no differences between the 3 agents with
respect to the peak and trough GLP-1 secretory responses [16e18,21].
In conclusion, we have established the circadian pattern of GLP-1
secretion in mice and shown that it is dependent on the core clock
gene Bmal1. We have also characterized secretagogin expression in
murine and human L-cells for the ﬁrst time, identifying secretagogin as
a novel regulator of circadian GLP-1 secretion: under the control of
rhythmic BMAL1 expression, SCGN binds to b-actin, is recruited to the
cell membrane in a time-dependent manner that is parallel to itsMOLECULAR METABOLISM 31 (2020) 124e137
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circadian expression and is required for stimulated-GLP-1 secretion.
Due to the insulinotropic effects of GLP-1, both long-acting GLP-1
receptor agonists and GLP-1 degradation inhibitors are used as a
therapy for type 2 diabetes [74]. SNARE regulators may provide a novel
target for type 2 diabetes therapies given their regulation of the
secretion of key metabolic hormones, including not only GLP-1, but
also insulin. Further investigation of the developing link between
circadian rhythms, diabetes, and obesity [49e51] and improved un-
derstanding of the molecular drivers behind the circadian secretion of
GLP-1 may therefore have therapeutic implications, including time-
sensitive therapies.
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